Per Persson, CEO
Acarix
Acoustic monitoring of coronary artery diseases of the heart. Modern tool for early and accurate CAD rule-out.
Visit website.
James Biggins, CEO
Access Vascular
Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access.
Visit website.
Todd Usen, CEO
Activ Surgical
Improving patient outcomes and reducing costs to healthcare systems through the integration of advanced computer vision, artificial intelligence and robotics designed to seamlessly fit within operating room workflow while providing advanced imaging and diagnostic accuracy during surgery.
Visit website.
Bob Cathcart, CEO
AiM Medical Robotics
MRI compatible robotic systems for the Neurosurgery market.
Visit website.
Marc Rippen, CEO
Alertgy
Real-time on demand blood glucose monitoring using non-invasive wristband technology.
Visit website.
Myles Greenberg, MD, President & CEO
Alucent Biomedical
Natural Vascular Scaffolding (NVS) is the first technology of its kind combining drug-device therapy into a breakthrough treatment designed to naturally open narrowed or blocked arteries and then durably maintain arterial patency. NVS was developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD).
Visit website.
Josh Rabinowitz, CEO
Articulate Labs
Wearable medical devices that augment regular activity to create convenient, mobile physical rehabilitation assistance. The first application of this platform technology is accelerated rehabilitation following knee replacement surgery through neuromuscular electrical stimulation of user's quadriceps muscles in synch with gait.
Visit website.
John Barrett, CEO
Auctus Surgical
Technology to treat pediatric scoliosis with non-fusion surgical system.
Visit website.
Nissan Elimelech, Founder & CEO
Augmedics
Advanced technologies aimed at revolutionizing surgical treatment. Initial product delivers augmented-reality head-mounted display for spine surgery which allows surgeons to see the patient’s anatomy through skin and tissue, as if they had "X-Ray Vision."
Visit website.
Ken Nelson, Chief Commercial Officer
Bardy Diagnostics
An innovator in digital health and remote patient monitoring, with a focus on providing the most diagnostically-accurate and patient-friendly cardiac patch monitors to the industry, including the award-winning Carnation Ambulatory Monitor (CAM™) patch.
Visit website.
Kevin Rocco, CEO
Biorez
Biorez is developing bio-inductive implants for the $7B sports medicine market that help restore joint stability and help direct the healing and regeneration of new functional tissue. After the healing process is complete, our implants are naturally broken down by the body, restoring the anatomy without the chronic risks of permanent synthetic materials.
Visit website.
Jonathan Gunn, CEO
Briteseed
Real-time intraoperative visualization to enhance surgeon confidence and prevent unintended bleeding.
Visit website.
Raj Reddy, CEO
Canary Health Technologies
Canary uses proven biomarkers and proprietary nanosensors to map and uncover hidden data in your breath, so cancers and other diseases can be detected early and treated more successfully.
Visit website.
William (Bill) Hunter, MD, MSc, CEO
Canary Medical
A medical data company improving healthcare outcomes through the continuous collection, analysis, and monetization of data derived from proprietary, "smart" medical devices that self-report on function, diagnostic information, patient activity, and side effects.
Visit website.
Shelley Savage, President & CEO
CardioThrive
Focused on making sudden cardiac arrest a routinely survivable event through the use of innovative and ultra-portable defibrillation technology.
Visit website.
Randy Hubbell, CEO
Carmell Therapeutics
Plasma-based Bioactive Materials (PBMs) to accelerate bone and soft tissue healing.
Visit website.
Ramin Mousavi, VP, Global Marketing & Strategy
CathWorks
CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize PCI therapy decisions and elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians.
Visit website.
Philip Rackliffe, CEO
Centerline Biomedical
A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
Visit website.
Randy Preston, Chief Business Officer
Centese
Transforming surgical drainage with intelligent digital devices to reduce complications and costs.
Visit website.
Benjamin Bobo, CEO
Cerenetex
Acoustic based platform, using A.I. to detect Large Vessel Occlusion (LVO) ischemic strokes reducing complications from delayed treatment.
Visit website.
Mohan Frick, CEO
ChemoTech
The company is dedicated to innovation in cancer care and recently launched IQwave. This technology performs electrochemotherapy which is approved for the treatment of a wide range of tumors.
Visit website.
Suzanne Babcock, Chairman & CEO
CivaTech Oncology
Innovative products that bring meaningful improvements to low dose rate brachytherapy. The CivaString® and CivaSheet® can substantially reduce procedure time, provide homogeneous dose distribution and minimize trauma. Customizable CivaTech products insure that radiation oncologists can deliver individualized, targeted therapy to treat cancer.
Visit website.
Paul Molloy, CEO
ClearFlow
A patented active blood and fluid evacuation system to speed recovery, reduce complications, and lower healthcare costs related to medical tube obstruction.
Visit website.
Philip Siberg, CEO
Coala Life
Patch-free Remote Heart Monitor that provides real-time diagnostic-quality ECG analysis and heart sound recordings simultaneously to the patient and healthcare provider.
Visit website.
Boaz Assaf, CEO
Colospan
An innovative intraluminal bypass device, preventing the profound clinical and economic pains associated with anastomotic leaks and diverting colonic stomas.
The company has achieved meaningful clinical milestones to date, is CE marked and has launched its FDA pivotal trial in Q3-19.
Visit website.
Colleen Gray, CEO
Consensus Orthopedics
A new portfolio of orthopedic technologies which will complement and leverage the company's current portfolio of total joint implants and other advanced surgical instruments.
Visit website.
William Altman, CEO
CorInnova
Minimally invasive, soft robotic cardiac device creating a new paradigm for heart failure treatment.
Visit website.
Osman Khawar, CEO
Diality
Smart, flexible, portable, home hemodialysis machine that will enable patients to treat themselves wherever they are.
Visit website.
Derrick Johns, CEO
DiFusion Technologies
ZFUZE is a new load bearing biomaterial which is invisible to the immune system and does not illicit a Foreign Body Response, but instead signals for pro reparative M2 Macrophage phenotypes
Visit website.
Claude Cohen-Bacrie, Founder, President & CEO
E-Scopics
E-Scopics is a French startup which democratizes ultrasound imaging to all healthcare professionals. It manufactures a digital transducer and a connected software APP to provides quantitative imaging for several medical conditions. The image formation process is no longer HW based but rather a SaaS running on a cell phone, a Tablet or the Cloud, with AI based algorithms for quantitative diagnosis.
Visit website.
Charles Gilbride, CEO
Elevation Spine
Innovating spinal implants with proven technology and materials using proprietary product designs.
Visit website.
Jeff Conroy, Co-Founder & CEO
Embody
Collagen-based implants for the treatment of tendon and ligament injuries.
Visit website.
Greg Mayes, CEO
Engage Therapeutics
The first and only rapid onset rescue treatment under investigation for patients with a recurrent and predictable pattern of epileptic seizures – it could become the "EpiPen" for patients with epilepsy.
Visit website.
Bill Phillips, President
Epic Neuro
Minimally invasive implantable device to provide brain stimulation and EEG recording for use in stroke rehab. The device is very small, simple to implant, inexpensive, and easy to remove when rehab is complete.
Visit website.
Randy AuCoin, President & CEO
Exact Imaging
Micro-ultrasound platform provides a practical solution as a new tool for urologists to perform targeted biopsies within a standard urological workflow.
Visit website.
Jennifer Fried, CEO
ExplORer Surgical
A data-driven approach to managing and improving the most complex surgical procedures.
Visit website.
Joseph Muldoon, CEO
FAST Biomedical
A medical technology company focused on the development of a patented technology for measuring plasma volume and kidney function.
Visit website.
Arnaud Mascarell, CEO
FineHeart
Implantable Cardiac Output Management System (ICOMS) is a novel, wirelessly powered, fully implantable mechanical circulatory support device that is able to optimize cardiac output while preserving the heart’s innate contractility.
Visit website.
Tej M. Singh, MD, CEO
Fist Assist
Wearable device for vein identification and enhancement for the ESRD patient.
Visit website.
Joe Eibl, CEO
Flosonics Medical
Non-invasive sensors to improve the management of critically ill patients.
Visit website.
Sridhar Prathikanti, MD, President
Future World Studios
Virtual reality healthcare integration.
Visit website.
John Viguerie, CEO
Glucorecs
Glucorecs is a Non-Invasive Blood Glucose Sensing technology in a tidy, portable, personal care form-factor called GluFit – the first device to comply with ISO-15197.
Visit website.
Valerie Perlowitz, CEO
Grace Wellness Products
Grace Wellness Products Inc. is the leader in rapid rehabilitation utilizing our patented Turnbow Butterfly device. Supplementing orthopedic surgeons and physical therapists, the Butterfly allows them to better care for patients during their rehabilitation, extends clinical capabilities, augments surgeon and therapist resources, and optimizes patient outcomes. Patient use of the Butterfly has demonstrated 20% decrease in rehabilitation time and has the potential to decrease the need for opioids. The Butterfly will be the first cloud based IoT enabled device that will: gather information about patient usage; provide physical therapists and orthopedic surgeons analytics, assisting patient rehabilitation plans; and assist patients in correct forms of exercise.
Visit website.
Lorenzo Pradella, CEO
GreenBone Ortho
Bone regenerating, load-bearing implants to treat severe fractures and conditions such as trauma and tumors that result in extensive bone loss
Visit website.
Faii Ong, Founder
GyroGear
A wearable glove device which mechanically stabilizes hand tremors in patients with Parkinson's disease and Essential Tremor.
Visit website.
Douglas Snell, Program Director
HAPPE Spine
Hydroxyapatite Porous PEEK (HAPPE) fabricated through proprietary technology to provide optimal mechanical properties of PEEK polymer materials, while providing improved surface texture inviting boney engagement, interconnected porosity for long term fixation, and the bioactive properties of HA to provide an effective construct for bone ingrowth. The HA further improves mechanical properties compared to standard PEEK, and all together, optimizes imaging for post operative diagnosis.
Visit website.
Nathan White, Ph.D., CEO
HealthLytix
Revolutionizing early disease detection through cutting-edge advances in genetics & medical imaging.
Visit website.
Mario Salerno, CEO
I-VASC
I-VASC is an innovative startup focused on the development of a patented proprietary minimally invasive medical device for the treatment of varicose veins.
Visit website.
Matthew Nojoomi, CEO & Co-Founder
Ictero Medical
Minimally invasive treatment for high risk surgical patients with gallstone disease. The CholeSafe System can be used in the interventional radiology suite with minimal local anesthesia to defunctionalize the gallbladder without having to remove it.
Visit website.
Brian Carrico, CEO
IHS
The IB-Stim is a percutaneous electrical nerve field stimulator (PENFS) system to treat abdominal pain associated with irritable bowel syndrome (IBS). The NSS-2 BRIDGE is a percutaneous nerve field stimulator (PNFS) device system that can be used as an aid to reduce the symptoms of opioid withdrawal.
Visit website.
Jason Bottiglieri, President & CEO
InnovHeart
Transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease.
Visit website.
Steve Stephansen, CEO
LifeWave Biomedical
A connected health solution that improves the clinical management of patients living with congestive heart failure (CHF) in hospital, ambulatory, and home settings. The solution comprises a small, non-invasive lung sensor that provides an absolute and accurate measurement of lung fluids and respiratory parameters.
Visit website.
William Dubiel, President & CEO
LightIntegra Technology
A medical device company focused on reducing transfusions, minimizing platelet refractoriness and reducing healthcare costs for blood cancer patients. The device, ThromboLUX, makes a rapid determination of platelet activation status, thus allowing proper allocation of platelet products to patient recipients.
Visit website.
Shahram Sharif, CEO
LindaCare
Remote monitoring solutions for implantable cardiac devices.
Visit website.
Dr. Ben Lipps, CEO and Chairman
Magforce
Nanotechnology-based therapy for the treatment of cancer.
Visit website.
Manny Villafaña, PhD, Sc, CEO
Medical 21
Developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.
Visit website.
Steve Lee, Founder & CEO
MediPines
A portable, non-invasive, point-of-care measurement device for respiratory gas exchange to deliver real-time respiratory status detection.
Visit website.
Thomas Dietiker, CEO
Medtor
Technology to transform accuracy in vital-sign monitoring and wearable devices with a patented spectral white light sensor. Designed for clinical grade mobile, the vital sign monitoring clears the way for broader applications.
Visit website.
Reid Rutherford, CEO
Melzi
Unintended retained foreign object (URFO) is the #1 "never-event" in hospitals. Melzi Sharps Finder helps surgeons inspect the surgical area for metal objects during open, laparoscopic, and robotic surgeries.
Visit website.
Michael Whitman, CEO
Micro Interventional Devices
Taking aim at structural heart disease -- treating mitral and tricuspid valve insufficiency.
Visit website.
Richard Oberreiter, CEO
Modulim
Optical imaging solutions powered by spatial frequency domain imaging that help clinicians assess compromised circulation.
Visit website.
David Huizenga, CEO
Moterum
High impact products in the field of mobility and rehabilitation for those who have survived a stroke, traumatic brain injury, or spinal injury.
Visit website.
Timothy P. Moran, CEO
Motus GI
Innovative solutions to address unmet needs in GI endoscopy, cost-effectively improving clinical outcomes that benefit patients, providers and payers worldwide.
Visit website.
Benjamin Holmes, CEO
Nanochon
Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3-D printing to create an implant which can permanently repair debilitating joint injuries. The implant can bear loads like a traditional joint implant, quickly restoring a patient’s movement.
Visit website.
Alan Lucas, CEO & Founder
Navigation Sciences
Developing Image-guided Video Assisted Thoracoscopic Surgery (iVATS) technology for minimally invasive identification and removal of early stage lung tumors and other soft tissue cancers.
Visit website.
Fred Colen, CEO
Neovasc
Specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace. Products include the Tiara™ technology in development for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer™ for the treatment of refractory angina.
Visit website.
Joseph Connell, Chairman
NeuEsse
Plant-based human skin substitute in either a protein material bandage or a "no-touch" application protocol device (especially for burns) that is lightweight, portable, military-grade and available at any point of injury to deliver skin substitutes along with other therapeutics for military and civilian patients.
Visit website.
Brian Shields, CEO
Neurent Medical
Minimally invasive hand-held radio-frequency device which ENT surgeons will use to treat patients in an office setting, removing the complications and costs associated with most surgical procedures.
Visit website.
Ana Maiques, CEO
Neuroelectrics
Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG.
Visit website.
Bryce Klontz, CEO
New View Surgical
On a mission to improve the outcomes and efficiency of laparoscopic surgical procedures through the introduction of patented VisionPort™ technology.
Visit website.
Thomas Marchand, CEO
NIDO
NIDO (Boston, MA) is a medical device company developing SEPIA, an innovative solution for epicardial VT ablation that has been initiated by two investigators at Boston Children’s Hospital and Harvard Medical School. SEPIA will allow safe access and real-time visualization of the epicardial surface. Ultimately it will reduce complications and improve ablation efficiency, leading to decrease recurrence of VT.
Visit website.
Stephen Merrick, CEO
NorthStar Medical
Nuclear medicine technology company committed to providing stable, domestic and environmentally friendly radioisotope supply solutions to meet the needs of patients and advance clinical research. Fundamentally transforming the ways that medical radioisotopes are produced and distributed around the world.
Visit website.
Stuart Mitchell, PhD, Founder & CEO
Novuson
Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.
Visit website.
Mark Greget, Founder & CEO
NuEyes
Augmented reality technology to help the visually impaired. Lightweight wearable electronic magnifier and hands free smartglass technologies.
Visit website.
Cristian Atria, Founder & CEO
nView Medical
3D imaging in surgery using AI image creation algorithms that merge prior information with real-time data gathered during surgery to reduce imaging time and to minimize x-ray radiation.
Visit website.
Ehsan Jabbarzadeh, CEO
Obsidio
Obsidio is pioneering a biomaterial platform technology to enable minimally-invasive occlusion of blood vessels anywhere in the body regardless of the patient’s coagulopathy.
Visit website.
Kurt Riegger, CEO
OcuSciences
A medical diagnostic device company developing a rapid, unique and patented non-invasive ocular imaging technique.
Visit website.
David Hochman, Chairman & CEO
Orchestra BioMed
Orchestra BioMed is a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine. The lead products in the Company’s pipeline include the Virtue® Sirolimus-Eluting Balloon for the treatment of artery disease and BackBeat™ Cardiac Neuromodulation Therapy for the treatment of hypertension.
Visit website.
Saverio La Francesca, MD, CEO
Orgagen
ORGAGEN has designed a technology platform for maintaining and restoring function in diseased, malformed or injured organs. We have developed a cellularized organ implant that unlocks the body’s own healing ability to regenerate new tissue and organs.
Visit website.
Claude LeDuc, CEO
Ortho Regenerative Technologies
Orthopedic biotechnology company developing novel therapeutic tissue repair devices to dramatically improve the success rate of Sports Medicine Surgeries.
Visit website.
Brian Verrier, CEO
Ossio
OSSIOfiber™ is a first-of-its-kind implant material stronger than cortical bone that leaves nothing permanent behind and is designed for rapid bone in-growth, regeneration and replacement.
Visit website.
Dean Sawyer, CEO
Palo Alto Health Sciences
Palo Alto Health Sciences, Inc. is a privately held Silicon Valley digital therapeutic company at the forefront of revolutionizing behavioral healthcare with evidence based, at-home, drug-free solutions.
Visit website.
Matt Angle, CEO
Paradromics
High-data rate brain computer interface. Paradromics envisions a future where data is exchanged seamlessly between brains and computers. Conditions such as blindness, paralysis, and mental illness, which today are considered untreatable, will be reframed as data problems with technological solutions.
Visit website.
Sinead E. Miller, PhD, CEO
Path Ex
Diagnosing and treating sepsis early with an extracorporeal blood cleansing device designed to selectively remove pathogens, including multi-drug resistant bacteria, and endotoxins from circulating blood.
Visit website.
Lishan Aklog, MD, Chairman & CEO
PAVmed
PAVmed’s current pipeline consists of six lead products focused on medical infusion, hand surgery, pediatric ear infections, and tissue ablation. PAVmed is building it's product pipeline and has new innovations which will be announced at the Summit.
Visit website.
Ryan Shelton, PhD, CEO & Co-Founder
PhotoniCare
The TOMi™ Scope uses an advanced light-based technology to see through the eardrum to fundamentally transform the diagnosis and treatment of middle ear infection.
Visit website.
Henri Justino, MD, Co-Founder
PolyVascular
Transforming the care of children with congenital heart disease through an entirely new generation of heart valves.
Visit website.
Bryan Lord, CEO
Pristine Surgical
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.
Visit website.
Amit Vohra, PhD, CEO
Promaxo
Next generation office-based modular MRI and MRI based technologies. Initial focus on advancing the solutions for prostate disease management and other urology and pelvic conditions.
Visit website.
William Wittmeyer, CEO
Pulmostics
Breath analysis diagnostic systems using advanced biomarker analytical technology and data analysis algorithms.
Visit website.
John Klock, CEO
QT Ultrasound
QT Ultrasound is a privately held technology company engaged in the research, development and commercialization of an innovative automated breast imaging system producing high-resolution transmission ultrasound images.
Visit website.
Edmond Rambod, PhD, Chairman & CEO
Quantason
Image-Based Dynamic Ultrasound Spectrography (IDUS) is a platform for radiation-free, proactive, early and preventive breast screening with no limiting factors such age, breast density, size, pregnancy or radiation therapy.
Visit website.
Shahid Azim, CEO
REACT Neuro
Merging clinical sensors with AI and consumer platforms and building algorithms that can predict early onset of the most significant brain health conditions.
Visit website.
Efrat Shenhod-Malihi, Founder & CEO
ReSymmetry
Healy is a pioneering proprietary technology, developed to introduce controlled, gentle movement of wheelchair elements, to meet the urgent need of wheelchair users. The individually tailored movement programs will improve blood circulation, greatly reduce the risk of secondary medical conditions, enhance wellbeing and improve the quality of life.
Visit website.
Jeremy Bridge-Cook, PhD, CEO
Rna Diagnostics
Innovation in personalized medicine for cancer therapy management.
Visit website.
Richard Hanbury, CEO
Sana Health
Non-invasive bio-therapeutic device for pain management.
Visit website.
Zaffer Syed, President & CEO
Saranas
The Early Bird® is designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, such as transcatheter aortic valve replacement, large bore hemodynamic support device placement, or other complex endovascular interventions, where the femoral artery or vein is used to gain vascular access.
Visit website.
Geoffrey Klass, CEO
Sense Diagnostics
The Sense devices is a non-invasive, disposable technology that continuously monitors brain activity primarily in the intensive care unit.
Visit website.
Berk Tas, President & CEO
SentiAR
Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.
Visit website.
Matt Ahearn, President & COO
Shoulder Innovations
Total shoulder replacement system that addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant.
Visit website.
Gabriele Grecchi, CEO & Co-Founder
Silk Biomaterials
A breakthrough technology platform which harnesses the natural properties of silk. The first application will be in nerve repair, with 510(k) clearance expected at the end of 2H20
Visit website.
David Narrow, CEO
Sonavex
Detecting flow compromise earlier using real-time, definitive, visual and quantitative blood flow monitoring — made possible with ultrasound.
Visit website.
Vipula Tailor, CEO
Sonix Medical Devices
Focused on eliminating pre and post-operative bacterial infections. Sonix-A8 technology kills bacteria on and below the surface of skin where traditional treatments cannot reach. A non-pharmaceutical, non-chemical, and non-UV light-based device to kill any all bacteria (Gram-negative or Gram-positive) including Superbugs like MRSA without giving rise to Antimicrobial Resistance (AMR) bugs.
Visit website.
Laura Perryman, CEO
StimGuard
Wireless office based urology product for incontinence.
Visit website.
Nick Delmonico, President & CEO
Strados Labs
User-friendly sensors, unique collection methodologies, and data processing software that creates a more holistic view of a patient's respiratory health.
Visit website.
Doug Daniels, CEO
Stroma Medical
STRŌMA® is the leader in permanent eye color change, with its revolutionary STRŌMA® Laser System. Its patented laser initiates a natural metabolic process that gradually eliminates the superficial pigment in darker eyes to reveal your natural underlying color.
Visit website.
Attila Borbath, CEO
Synergia Medical
Leveraging photonics to create a platform for small, safe and long-lasting neurostimulators.
Visit website.
Ron Solar, CEO
ThermopeutiX
The Company’s current product line — a proprietary family of patented and patent-pending CoolTools™— addresses the next frontiers in interventional medicine, advancing the treatment of vascular-related disorders and using the body’s vascular system to provide therapy.
Visit website.
Jennifer Ernst, CEO & Co-Founder
Tivic Health
A bioelectronic health-tech company that translates neuroscience into consumer-friendly medical devices for therapeutic benefit.
Visit website.
Mark Foster, CEO
Trice Medical
Improving minimally invasive orthopedic diagnostics for the patient and physician providing instant answers.
Visit website.
Ralph Zipper, CEO
UroShape
SoLá Therapy is a proprietary photobiomodulaiton laser and method for treating muscle pain and spasm in those persons suffering from chronic pelvic pain.
Visit website.
Allison London Brown, CEO
UVision360
The Luminelle DTx Hysteroscopy System to support the market shift to office based procedures. Dedicated to the advancement of a fully integrated hysteroscopy and cystoscopy system to fulfill unmet needs for diagnostic & therapeutic procedures for the modern office.
Visit website.
Oren Goldshtein, Co-Founder & CEO
Vectorious
A system designed to provide reliable, remote monitoring of left atrial pressure (LAP) in the home as needed for the optimal treatment of heart failure patients.
Visit website.
Bill Skillman, President & CEO
Velico Medical
Proprietary technologies to improve the quality, availability and economics of platelets and plasma (human blood components) for transfusion.
Visit website.
Paul Leake, CEO
VerteCore
Innovative orthopedic devices to allow ambulatory, non-surgical treatment of spinal disorders, mitigating the need for drugs and surgical intervention.
Visit website.
Vinayak Nandalike, Founder
Yostra
NEURO TOUCH™ is a point of care screening device for Peripheral Neuropathy. KADAM is a revolutionary therapeutic device to reduce the healing time of the chronic wounds, combining simplicity with the state of the art technologies in wound care.
Visit website.
John Barrett, CEO
ZKR Orthopedics
New procedure to mimic the clinical effects of tibial osteotomy procedures. Implants will be delivered to the proximal tibia below the patellar tendon, offloading and re-directing the tendon to reduce pain and inflammation.
Visit website.